US Patent Issued to Renew Biopharma on Feb. 3 for "Compositions and methods for using genetically modified enzymes" (California Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,315, issued on Feb. 3, was assigned to Renew Biopharma Inc. (San Diego).

"Compositions and methods for using genetically modified enzymes" was invented by Michael Mendez (San Diego), Joseph Noel (San Diego), Michael Burkart (San Diego), Jeremy Lanoiselee (San Diego), Kyle Botsch (La Mesa, Calif.) and Matthew Saunders (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to the biosynthesis of cannabinoids and related prenylated phenolic compounds using recombinant enzymes. In particular, the disclosure provides recombinant prenyltransferase enzymes engineered to produce a greater amount of a desired product, or to have a gr...